Which flexible ureteroscope is the best for upper tract urothelial carcinoma treatment?


Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 07 01 2019
accepted: 05 02 2019
pubmed: 17 2 2019
medline: 18 3 2020
entrez: 17 2 2019
Statut: ppublish

Résumé

To present attributes of currently available flexible ureteroscopes to define the best flexible ureteroscope for upper tract urothelial carcinoma (UTUC) treatment. Scopus and Medline databases were searched for articles relating to performance of flexible ureteroscopes. A consensus for final inclusion of articles judged to be relevant for UTUC treatment was reached between the authors. Instrument characteristics were extracted from manufacturers' product brochures. Smaller cross-sectional size of instruments is associated with increased probability for successful primary access to the upper urinary tract. The smallest flexible ureteroscopes are fiberoptic scopes. Smaller ureteroscopes also allow comparatively increased irrigation flow at constant intrarenal pressure. Digital flexible ureteroscopes achieve superior image quality compared to their fiberoptic counterparts, at the price of lower end-deflection ability. Image enhancement technologies such as narrow-band imaging (NBI), photodynamic diagnosis (PDD) and Image 1-S (formerly SPIES) are based on subjective image interpretation by the operator. NBI and PDD significantly increase tumor detection rate. The highest subjective image quality score of the Image 1-S technology is reached by the "Clara + Chroma" mode. Single-use ureteroscopes offer potential advantages over reusable scopes, including sterility, absence of contamination, immediate availability and exemption of previous instrument wear. Miniaturization, digital image caption and image enhancement technologies seem to be the major determinants defining the best flexible ureteroscope for UTUC treatment. The impact of further factors, such as distal tip design, torque, working channel position, risk of contamination, as well as upcoming technological innovations should be evaluated in randomized controlled trials.

Identifiants

pubmed: 30770944
doi: 10.1007/s00345-019-02675-0
pii: 10.1007/s00345-019-02675-0
doi:

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2325-2333

Références

J Endourol. 2001 Aug;15(6):615-8
pubmed: 11552787
Urol Clin North Am. 1988 Aug;15(3):541-6
pubmed: 3407043
Arab J Urol. 2017 Mar 06;15(2):100-109
pubmed: 29071138
Invest Radiol. 1981 May-Jun;16(3):206-14
pubmed: 7263154
J Urol. 2006 Jul;176(1):137-41
pubmed: 16753388
Opt Lett. 2003 Aug 15;28(16):1436-8
pubmed: 12943083
Urology. 2013 Nov;82(5):1017-9
pubmed: 24001703
Eur Urol. 2008 Jun;53(6):1138-48
pubmed: 18096307
BJU Int. 2018 Dec;122(6):959-969
pubmed: 29752769
J Endourol. 2016 Jan;30(1):49-55
pubmed: 26381037
Eur Urol Focus. 2019 Nov;5(6):1105-1111
pubmed: 29534873
World J Urol. 2017 Mar;35(3):355-365
pubmed: 27233780
Photodiagnosis Photodyn Ther. 2010 Mar;7(1):39-43
pubmed: 20230992
Urol Int. 2014;93(4):384-8
pubmed: 25059717
World J Urol. 2017 Mar;35(3):379-387
pubmed: 27604375
Urology. 2018 Jul;117:89-94
pubmed: 29630955
J Endourol. 2009 Jun;23(6):903-5
pubmed: 19445639
J Endourol. 2006 Aug;20(8):552-5
pubmed: 16903813
Am J Infect Control. 2017 Aug 1;45(8):888-895
pubmed: 28625700
Urol Clin North Am. 2004 Feb;31(1):33-42
pubmed: 15040399
J Urol. 2000 Nov;164(5):1523-5
pubmed: 11025695
BJU Int. 2005 May;95(7):1043-4
pubmed: 15839928
J Endourol. 2010 Dec;24(12):1915-20
pubmed: 21067276
Clin Endosc. 2015 Nov;48(6):476-80
pubmed: 26668792
J Endourol. 2010 Dec;24(12):1929-34
pubmed: 21043835
Photodiagnosis Photodyn Ther. 2016 Mar;13:255-260
pubmed: 26256824
Urol Clin North Am. 2019 May;46(2):147-163
pubmed: 30961849
Curr Opin Urol. 2017 Mar;27(2):176-181
pubmed: 28027075
J Endourol. 2017 Jul;31(7):630-637
pubmed: 28478744
Eur Urol. 2016 Jul;70(1):188-194
pubmed: 27086502
J Endourol. 2017 May;31(5):468-475
pubmed: 28287823
J Endourol. 2016 May;30(5):602-8
pubmed: 26743929
Eur J Cancer. 2012 Mar;48(4):456-64
pubmed: 22119351
J Endourol. 2011 Jan;25(1):19-23
pubmed: 21247287
J Urol. 2005 Jun;173(6):2017-21
pubmed: 15879808
J Endourol. 2017 May;31(5):522-527
pubmed: 28381092
Urology. 2014 Oct;84(4):740-2
pubmed: 25150179
J Endourol. 2018 Jun;32(6):523-528
pubmed: 29562765
Eur Urol. 2018 Jan;73(1):111-122
pubmed: 28867446
J Hosp Infect. 2013 Oct;85(2):118-24
pubmed: 23954065
J Endourol. 2017 Oct;31(10):1062-1066
pubmed: 28817961
J Endourol. 2017 Oct;31(10):1090-1095
pubmed: 28835120
Asian J Androl. 2005 Dec;7(4):433-8
pubmed: 16281093
J Endourol. 2016 Jun;30(6):655-9
pubmed: 27084572
Urology. 1997 Sep;50(3):337-40
pubmed: 9301694
AJR Am J Roentgenol. 2004 Apr;182(4):1039-41
pubmed: 15039184
J Endourol. 2007 Sep;21(9):985-92
pubmed: 17941773
Int Braz J Urol. 2017 May-Jun;43(3):476-480
pubmed: 28338307

Auteurs

Etienne Xavier Keller (EX)

Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Sorbonne Université, Service d'Urologie, Assistance-Publique Hôpitaux de Paris, Hôpital Tenon, 4 Rue de la Chine, 75020, Paris, France.
Sorbonne Université, Groupe de Recherche Clinique sur la Lithiase Urinaire (GRC n°20), Hôpital Tenon, 75020, Paris, France.

Steeve Doizi (S)

Sorbonne Université, Service d'Urologie, Assistance-Publique Hôpitaux de Paris, Hôpital Tenon, 4 Rue de la Chine, 75020, Paris, France.
Sorbonne Université, Groupe de Recherche Clinique sur la Lithiase Urinaire (GRC n°20), Hôpital Tenon, 75020, Paris, France.

Luca Villa (L)

Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

Olivier Traxer (O)

Sorbonne Université, Service d'Urologie, Assistance-Publique Hôpitaux de Paris, Hôpital Tenon, 4 Rue de la Chine, 75020, Paris, France. olivier.traxer@aphp.fr.
Sorbonne Université, Groupe de Recherche Clinique sur la Lithiase Urinaire (GRC n°20), Hôpital Tenon, 75020, Paris, France. olivier.traxer@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH